Skip to main content

Appendix Cancer Awareness Month With Thomas Abrams, MD

In honor of Appendix Cancer Awareness Month this August, Dr. Thomas Abrams, Editor-in-Chief of Oncology Data Advisor and Assistant Professor of Medicine at Harvard Medical School, sat down to explain the different subtypes and presentations of appendix cancer, factors he takes into consideration when making treatment decisions, and the messages he hopes to convey to both clinicians and patients with the goal of raising awareness for this rare disease.  

Continue reading

Appendix Cancer Awareness Month With Thomas Abrams, MD

In honor of Appendix Cancer Awareness Month this August, Dr. Thomas Abrams, Editor-in-Chief of Oncology Data Advisor and Assistant Professor of Medicine at Harvard Medical School, sat down to explain the different subtypes and presentations of appendix cancer, factors he takes into consideration when making treatment decisions, and the messages he hopes to convey to both clinicians and patients with the goal of raising awareness for this rare disease.  

Continue reading

Appendix Cancer Model Predicts Efficacy of Chemotherapy

Because appendix cancer is rare, with only 1,000 people diagnosed in the United States every year, it is not as well understood as more common tumor types. That might change with the development of a patient-specific organoid model of the appendix which allows physicians to predict the efficacy of chemotherapy treatments prior to beginning them. Since every patient responds differently to treatment, this model, created by scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) ...

Continue reading